Insomnia Market Size To Hit US$ 6.1 Billion By 2028 | IMARC Group

According to IMARC Group's latest report, titled " 𝐈𝐧𝐬𝐨𝐦𝐧𝐢𝐚 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐒𝐡𝐚𝐫𝐞, 𝐒𝐢𝐳𝐞, 𝐆𝐫𝐨𝐰𝐭𝐡, 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 2023-2028", the Insomnia market reached US$ 5.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.1 Billion by 2028, exhibiting a CAGR of 3% during 2023-2028.

Insomnia represent numerous additives that are added to animal feed to convert the toxins into less toxic products. They act as bio-transforming agents to prevent the contamination of feed by mycotoxins that can negatively impact animal health, leading to problems related to reproduction, performance, or organ damage, such as liver and kidney. In recent times, mycotoxin detoxifiers have gained traction among farmers, as they aid in protecting animals against several diseases and promote proper growth in livestock.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝐅𝗿𝗲𝗲 𝐒𝗮𝗺𝗽𝗹𝗲 𝐁𝗿𝗼𝗰𝗵𝘂𝗿𝗲: https://www.imarcgroup.com/insomnia-market/requestsample

𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐬𝐨𝐦𝐧𝐢𝐚 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬

The expanding compound feed sector and the increasing consumption of animal-based products among the masses, including dairy, eggs, meat, etc., are among the key factors stimulating the Insomnia market. Moreover, the growing prevalence of mycotoxins in animal feed crops, such as maize, on account of unfavorable weather conditions, is acting as another significant growth-inducing factor.

Besides this, the increasing awareness regarding the benefits of Insomnia among farmers is positively influencing the global market. Furthermore, the escalating demand for high-quality food and the inflating focus on animal health are accelerating the adoption of mycotoxin detoxifiers in animal fodder, which is also propelling the market growth. Apart from this, the implementation of advanced animal husbandry practices to enhance meat quality and the growing livestock population are further fueling the global market. Additionally, various investments by the leading manufacturers in R&D activities to introduce nutritious feed additives and expand their product portfolio are also driving the market growth. In addition to this, the rising concerns regarding food safety, easy availability of raw materials, the inflating disposable income levels of consumers, and the launch of favorable government initiatives are anticipated to fuel the Insomnia market over the forecasted period.

𝗖𝗵𝗲𝗰𝗸𝗼𝘂𝘁 𝗡𝗼𝘄: https://www.imarcgroup.com/checkout?id=6148&method=1

𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐬𝐨𝐦𝐧𝐢𝐚 𝐌𝐚𝐫𝐤𝐞𝐭 2023-2028 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

The competitive landscape of the Insomnia market has been studied in the report with the detailed profiles of the key players operating in the market.

𝗦𝗼𝗺𝗲 𝗼𝗳 𝘁𝗵𝗲𝘀𝗲 𝗸𝗲𝘆 𝗽𝗹𝗮𝘆𝗲𝗿𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲:

Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.

𝗞𝗲𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:

The report has segmented the Insomnia market bases on therapy type, drug class and distribution channel.

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐓𝐲𝐩𝐞:
• Non-Pharmacological Therapy
o Hypnotherapy
o Cognitive Behavioral Therapy
o Medical Devices
o Others
• Pharmacological Therapy
o Prescription Sleep Aids
o Over-The-Counter Sleep Aids

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐃𝐫𝐮𝐠 𝐂𝐥𝐚𝐬𝐬::
• Antidepressants
• Melatonin Antagonist
• Benzodiazepines
• Nonbenzodiazepines
• Orexin Antagonist
• Others

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥:
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐑𝐞𝐠𝐢𝐨𝐧:

North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa

𝗔𝘀𝗸 𝗔𝗻𝗮𝗹𝘆𝘀𝘁 𝗳𝗼𝗿 𝟭𝟬% 𝗳𝗿𝗲𝗲 𝗰𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲𝗱 𝗿𝗲𝗽𝗼𝗿𝘁: https://www.imarcgroup.com/insomnia-market

𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗥𝗲𝗽𝗼𝗿𝘁:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝗦:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 |
Europe & Africa: +44-753-713-2163 |
Asia: +91-120-433-0800

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.